BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38721679)

  • 1. Ferroptosis in renal fibrosis: a mini-review.
    Yang SQ; Zhao X; Zhang J; Liao DY; Wang YH; Wang YG
    J Drug Target; 2024 May; ():1-9. PubMed ID: 38721679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases.
    Xu M; Zhang D; Yan J
    Phytomedicine; 2024 Jun; 130():155738. PubMed ID: 38824825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms of ferroptosis and its role in atherosclerosis.
    Xu X; Xu XD; Ma MQ; Liang Y; Cai YB; Zhu ZX; Xu T; Zhu L; Ren K
    Biomed Pharmacother; 2024 Feb; 171():116112. PubMed ID: 38171246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis and renal fibrosis: A new target for the future (Review).
    Zhang HY; Cheng M; Zhang L; Wang YP
    Exp Ther Med; 2023 Jan; 25(1):13. PubMed ID: 36561607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives.
    Han Z; Luo Y; Chen H; Zhang G; You L; Zhang M; Lin Y; Yuan L; Zhou S
    Kidney Dis (Basel); 2024 Jun; 10(3):224-236. PubMed ID: 38835406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
    Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.
    Zhang X; Li X
    Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis: Death by Lipid Peroxidation.
    Yang WS; Stockwell BR
    Trends Cell Biol; 2016 Mar; 26(3):165-176. PubMed ID: 26653790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ferroptosis in kidney tubular cell death under diabetic conditions.
    Kim S; Kang SW; Joo J; Han SH; Shin H; Nam BY; Park J; Yoo TH; Kim G; Lee P; Park JT
    Cell Death Dis; 2021 Feb; 12(2):160. PubMed ID: 33558472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury.
    Hosohata K; Harnsirikarn T; Chokesuwattanaskul S
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis and Liver Fibrosis.
    Pan Q; Luo Y; Xia Q; He K
    Int J Med Sci; 2021; 18(15):3361-3366. PubMed ID: 34522161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases.
    Feng Q; Yang Y; Ren K; Qiao Y; Sun Z; Pan S; Liu F; Liu Y; Huo J; Liu D; Liu Z
    Int J Biol Sci; 2023; 19(12):3726-3743. PubMed ID: 37564215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis.
    Zhang B; Chen X; Ru F; Gan Y; Li B; Xia W; Dai G; He Y; Chen Z
    Cell Death Dis; 2021 Sep; 12(9):843. PubMed ID: 34511597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis: An emerging therapeutic opportunity for cancer.
    Wang L; Chen X; Yan C
    Genes Dis; 2022 Mar; 9(2):334-346. PubMed ID: 35224150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between ferroptosis and mitophagy in renal fibrosis: a systematic review.
    Zhang M; Tong Z; Wang Y; Fu W; Meng Y; Huang J; Sun L
    J Drug Target; 2023 Sep; 31(8):858-866. PubMed ID: 37607069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. System X
    Li FJ; Long HZ; Zhou ZW; Luo HY; Xu SG; Gao LC
    Front Pharmacol; 2022; 13():910292. PubMed ID: 36105219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy.
    Latunde-Dada GO
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1893-1900. PubMed ID: 28552631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis as a new therapeutic opportunity for nonviral liver disease.
    Jia M; Zhang H; Qin Q; Hou Y; Zhang X; Chen D; Zhang H; Chen Y
    Eur J Pharmacol; 2021 Oct; 908():174319. PubMed ID: 34252441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review).
    Ocansey DKW; Yuan J; Wei Z; Mao F; Zhang Z
    Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37203397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenter of liver regeneration protects the kidney from ischaemia-reperfusion injury in ferroptosis.
    Huang LL; Liao XH; Sun H; Jiang X; Liu Q; Zhang L
    J Cell Mol Med; 2019 Jun; 23(6):4153-4164. PubMed ID: 30993878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.